AT III in septicemia with DIC
Related Experiment Video
Updated: Nov 8, 2026

Quantification of Violacein in Chromobacterium violaceum and Its Inhibition by Bioactive Compounds
Published on: August 8, 2025
1Medizinische Klinik I, Städtisches Krankenhaus Hildesheim, Germany.
Abstract:
In the development of sepsis DIC is a common complication. Several studies presented in this paper show a coincidence between the development of DIC and depletion of Antithrombin III, a serine protease inhibitor which inhibits a large scale of activated clotting factors. It seems very probable that substitution therapy should be of benefit in the treatment of sepsis-related DIC and may improve the outcome of septic patients. Physiological and clinical findings are put together to clarify the basic rationale for running clinical trials and future studies.
More Related Videos
11:003D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
Published on: October 17, 2025
11:17Monitoring Changes in Membrane Polarity, Membrane Integrity, and Intracellular Ion Concentrations in Streptococcus pneumoniae Using Fluorescent Dyes
Published on: February 17, 2014
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Endocarditis III: Medical Management
Three-Dimensional Microscopy in Microbiology
Peptic Ulcer Disease III: Clinical Manifestations and Complications